摘要:
The present invention relates to a material that is able to selectively inactivate a specific biologically harmful substance through photocatalysis, and uses thereof. The photocatalytic material (4) provided by the present invention comprises a holding substance (8) having holding specificity of selectively holding a specific biologically harmful substance (2), a photocatalyst (5) that is able to inactivate the harmful substance (2) held by the holding substance (8) through photocatalysis, and bridging molecules (7) that link the holding substance (8) to the photocatalyst (5), the bridging molecules (7) being arranged on the surface of the photocatalyst (5) in the form of a monolayer.
摘要:
A medicine for treating or ameliorating a disease associated with humoral immunity in the materno-fetal relationship, for example, sterility and infertility caused by humoral immunity in the materno-fetal relationship, blood type incompatible pregnancy, or fetal hemochromatosis, the medicine including, as an active ingredient, a compound selected from the group consisting of: (i) a compound represented by Formula (I) (wherein the respective reference numerals are as described in the specification) or a pharmaceutically acceptable salt thereof, (ii) a cyclosporine, and (iii) a rapamycin derivative.
摘要:
Provided are: a medicine for improving the state of pregnancy, which comprises a compound represented by general formula (I) or a pharmaceutically acceptable salt thereof as an active ingredient; and a use of the medicine.
摘要:
A material (10) for treating a harmful substance, characterized in that it comprises a holding substance (13) having a specificity of holding only a specific harmful substance (3) such as a virus, a bacterium or a toxicant which is or may be incorporated into a material to be treated in the form of a liquid or gas phase and a transition metal oxide deactivating the above harmful substance held by the holding substance (13) through the function as a photocatalyst.
摘要:
Provided are: a medicine for improving the state of pregnancy, which comprises a compound represented by general formula (I) or a pharmaceutically acceptable salt thereof as an active ingredient; and a use of the medicine.
摘要:
Provided is a medicine for inhibiting over-activated immunity before pregnancy or over-reactive immunity after pregnancy and restoring normal immune state. A medicine for inhibiting over-activated immunity before pregnancy or over-reactive immunity after pregnancy and restoring a normal immune state, the medicine including, as an active ingredient, a compound selected from the group consisting of: (i) a compound represented by Formula (I) or a pharmaceutically acceptable salt thereof
(wherein the respective reference numerals are as described in the specification), (ii) a cyclosporine, and (iii) rapamycin or a derivative thereof.
摘要:
Provided are: a medicine for improving the state of pregnancy, which comprises a compound represented by general formula (I) or a pharmaceutically acceptable salt thereof as an active ingredient; and a use of the medicine.
摘要:
A hazardous substance treatment agent has a retainer and a transition metal oxide. The retainer has the specificity of retaining only a specific hazardous substance, such as a virus, a bacterium or a toxin, that has become mixed in or has the possibility of becoming mixed in a treatment subject, such as blood, that is in at least either a liquid or gaseous phase. By a photocatalytic action, the transition metal oxide inactivates said hazardous substance retained by the retainer.